518 related articles for article (PubMed ID: 25499268)
21. Unique Regulatory Properties of Heterotetrameric Inositol 1,4,5-Trisphosphate Receptors Revealed by Studying Concatenated Receptor Constructs.
Chandrasekhar R; Alzayady KJ; Wagner LE; Yule DI
J Biol Chem; 2016 Mar; 291(10):4846-60. PubMed ID: 26755721
[TBL] [Abstract][Full Text] [Related]
22. The BH4 domain of Bcl-2 inhibits ER calcium release and apoptosis by binding the regulatory and coupling domain of the IP3 receptor.
Rong YP; Bultynck G; Aromolaran AS; Zhong F; Parys JB; De Smedt H; Mignery GA; Roderick HL; Bootman MD; Distelhorst CW
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14397-402. PubMed ID: 19706527
[TBL] [Abstract][Full Text] [Related]
23. IP3 receptor type 2 deficiency is associated with a secretory defect in the pancreatic acinar cell and an accumulation of zymogen granules.
Orabi AI; Luo Y; Ahmad MU; Shah AU; Mannan Z; Wang D; Sarwar S; Muili KA; Shugrue C; Kolodecik TR; Singh VP; Lowe ME; Thrower E; Chen J; Husain SZ
PLoS One; 2012; 7(11):e48465. PubMed ID: 23185258
[TBL] [Abstract][Full Text] [Related]
24. The BRCA1 tumor suppressor binds to inositol 1,4,5-trisphosphate receptors to stimulate apoptotic calcium release.
Hedgepeth SC; Garcia MI; Wagner LE; Rodriguez AM; Chintapalli SV; Snyder RR; Hankins GD; Henderson BR; Brodie KM; Yule DI; van Rossum DB; Boehning D
J Biol Chem; 2015 Mar; 290(11):7304-13. PubMed ID: 25645916
[TBL] [Abstract][Full Text] [Related]
25. Type 2 inositol trisphosphate receptor gene expression in hepatocytes is regulated by cyclic AMP.
Kruglov E; Ananthanarayanan M; Sousa P; Weerachayaphorn J; Guerra MT; Nathanson MH
Biochem Biophys Res Commun; 2017 May; 486(3):659-664. PubMed ID: 28327356
[TBL] [Abstract][Full Text] [Related]
26. The BH4 domain of Bcl-2 orthologues from different classes of vertebrates can act as an evolutionary conserved inhibitor of IP
Ivanova H; Luyten T; Decrock E; Vervliet T; Leybaert L; Parys JB; Bultynck G
Cell Calcium; 2017 Mar; 62():41-46. PubMed ID: 28179071
[TBL] [Abstract][Full Text] [Related]
27. Ligand sensitivity of type-1 inositol 1,4,5-trisphosphate receptor is enhanced by the D2594K mutation.
Tambeaux A; Aguilar-Sánchez Y; Santiago DJ; Mascitti M; DiNovo KM; Mejía-Alvarez R; Fill M; Wayne Chen SR; Ramos-Franco J
Pflugers Arch; 2023 May; 475(5):569-581. PubMed ID: 36881190
[TBL] [Abstract][Full Text] [Related]
28. The IP3 receptor as a hub for Bcl-2 family proteins in cell death control and beyond.
Parys JB
Sci Signal; 2014 Feb; 7(312):pe4. PubMed ID: 24518292
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis protection by Mcl-1 and Bcl-2 modulation of inositol 1,4,5-trisphosphate receptor-dependent Ca2+ signaling.
Eckenrode EF; Yang J; Velmurugan GV; Foskett JK; White C
J Biol Chem; 2010 Apr; 285(18):13678-84. PubMed ID: 20189983
[TBL] [Abstract][Full Text] [Related]
30. The IP3 receptor/Ca2+ channel and its cellular function.
Mikoshiba K
Biochem Soc Symp; 2007; (74):9-22. PubMed ID: 17233576
[TBL] [Abstract][Full Text] [Related]
31. Bcl-2 regulation of the inositol 1,4,5-trisphosphate receptor and calcium signaling in normal and malignant lymphocytes: potential new target for cancer treatment.
Greenberg EF; Lavik AR; Distelhorst CW
Biochim Biophys Acta; 2014 Oct; 1843(10):2205-10. PubMed ID: 24642270
[TBL] [Abstract][Full Text] [Related]
32. Bcl-2 interaction with the inositol 1,4,5-trisphosphate receptor: role in Ca(2+) signaling and disease.
Distelhorst CW; Bootman MD
Cell Calcium; 2011 Sep; 50(3):234-41. PubMed ID: 21628070
[TBL] [Abstract][Full Text] [Related]
33. Reduction of Mitochondria-Endoplasmic Reticulum Interactions by Acetylcholine Protects Human Umbilical Vein Endothelial Cells From Hypoxia/Reoxygenation Injury.
He X; Bi XY; Lu XZ; Zhao M; Yu XJ; Sun L; Xu M; Wier WG; Zang WJ
Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1623-34. PubMed ID: 25977565
[TBL] [Abstract][Full Text] [Related]
34. Inositol 1,4,5-trisphosphate receptor 2 as a novel marker of vasculature to delineate processes of cardiopulmonary development.
Ishizaki-Asami R; Uchida K; Tsuchihashi T; Shibata A; Kodo K; Emoto K; Mikoshiba K; Takahashi T; Yamagishi H
Dev Biol; 2020 Feb; 458(2):237-245. PubMed ID: 31758944
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of type 2 and type 3 inositol 1,4,5-trisphosphate receptor mRNAs in various mouse tissues: in situ hybridization study.
Fujino I; Yamada N; Miyawaki A; Hasegawa M; Furuichi T; Mikoshiba K
Cell Tissue Res; 1995 May; 280(2):201-10. PubMed ID: 7781020
[TBL] [Abstract][Full Text] [Related]
36. Astrocytic Ca
Okubo Y
J Pharmacol Sci; 2020 Oct; 144(2):83-88. PubMed ID: 32709559
[TBL] [Abstract][Full Text] [Related]
37. Regulation of inositol 1,4,5-trisphosphate-induced Ca
Arias-Del-Val J; Santo-Domingo J; García-Casas P; Alvarez-Illera P; Núñez Galindo A; Wiederkehr A; Fonteriz RI; Montero M; Alvarez J
Cell Calcium; 2019 Jan; 77():68-76. PubMed ID: 30557841
[TBL] [Abstract][Full Text] [Related]
38. IP
Roest G; La Rovere RM; Bultynck G; Parys JB
Adv Exp Med Biol; 2017; 981():149-178. PubMed ID: 29594861
[TBL] [Abstract][Full Text] [Related]
39. Structural and dynamic insights into the subtype-specific IP3-binding mechanism of the IP3 receptor.
Lee SY; Yoo HS; Choi HS; Chung KY; Seo MD
Biochem J; 2016 Oct; 473(20):3533-3543. PubMed ID: 27444647
[TBL] [Abstract][Full Text] [Related]
40. Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum.
Oakes SA; Scorrano L; Opferman JT; Bassik MC; Nishino M; Pozzan T; Korsmeyer SJ
Proc Natl Acad Sci U S A; 2005 Jan; 102(1):105-10. PubMed ID: 15613488
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
